Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
Privia Health Group, Inc. (PRVA)
Company Research
Source: Yahoo! Finance
Privia Health Group, Inc. All 2025 Operating and Financial Metrics At or Above High End of Guidance Ranges Full-year 2025 Net Income from Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from Full-year 2025 Net Cash Provided by Operating Activities of $163.4 Million from 2024; Year-end 2025 Cash Balance of Million and No Debt 2026 Guidance Reflects ~20% Adjusted EBITDA Growth at Midpoint ARLINGTON, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Each of the Company's operating and financial performance metrics were at or above the high end of its guidance ranges for 2025, as highlighted below. Full-Year Performance For the Years Ended December 31, ($ in millions, except per share amounts) Change (%) Total revenue Gross profit Operating income Net income a Non-GAAP adjusted net income b Net income per dilu
Show less
Read more
Impact Snapshot
Event Time:
PRVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRVA alerts
High impacting Privia Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
PRVA
News
- Privia Health Group (PRVA) had its price target lowered by Citigroup Inc. from $34.00 to $32.00. They now have a "buy" rating on the stock.MarketBeat
- Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration [Yahoo! Finance]Yahoo! Finance
- Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry CollaborationBusiness Wire
- Privia Health price target raised to $33 from $31 at Truist [Yahoo! Finance]Yahoo! Finance
- Privia Health Group (PRVA) had its price target raised by Truist Financial Corporation from $31.00 to $33.00. They now have a "buy" rating on the stock.MarketBeat
PRVA
Earnings
- 2/26/26 - Beat
PRVA
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- 2/27/26 - Form 144
- PRVA's page on the SEC website